Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level 

 1  Agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
 
 3  Agents affecting metabolism
 
 4  Agents affecting cellular function
   41  Cellular function activating agents
   42  Antineoplastics
   43  Radioactive drugs
   44  Allergic agents
     441  Antihistamines
     442  Stimulation therapy agents
     443  Nonspecific immunogen preparations
     449  Miscellaneous
       4490  Miscellaneous
         D00526  Cromolyn sodium (USP); Sodium cromoglicate (JP18)
         D01136  Tranexamic acid (JP18/USP/INN)
         D04492  Icatibant acetate (JAN/USAN)
         D11094  Lanadelumab (USAN); Lanadelumab (genetical recombination) (JAN)
         D11674  Berotralstat hydrochloride (JAN/USAN)
         D10354  Dupilumab (USAN/INN); Dupilumab (genetical recombination) (JAN)
         D09979  Tralokinumab (USAN/INN); Tralokinumab (genetical recombination) (JAN)
         D11400  Abrocitinib (JAN/USAN)
         D09633  Lebrikizumab (USAN/INN); Lebrikizumab (genetical recombination) (JAN)
         D11080  Nemolizumab (USAN/INN); Nemolizumab (genetical recombination) (JAN)
         D00659  Azelastine hydrochloride (JP18/USP)
         D01192  Olopatadine hydrochloride (JP18/USP)
         D10252  Fexofenadine hydrochloride and pseudoephedrine hydrochloride
         D02732  Pranlukast hydrate (JP18)
         D00529  Montelukast sodium (JP18/USP)
         D01385  Ibudilast (JP18/INN)
         D05251  Omalizumab (USAN/INN); Omalizumab (genetical recombination) (JAN)
         D01123  Seratrodast (JAN/USAN/INN)
         D01773  Oxatomide (JAN/USAN/INN)
         D00664  Cetirizine hydrochloride (JP18/USP)
         D08118  Levocetirizine dihydrochloride (USP); Levocetirizine hydrochloride (JAN)
         D00364  Loratadine (JAN/USP/INN)
         D01332  Ketotifen fumarate (JP18/USAN)
         D01478  Ebastine (JP18/USAN/INN)
         D01713  Epinastine hydrochloride (JAN)
         D00671  Fexofenadine hydrochloride (JP18/USP)
         D03693  Desloratadine (JAN/USP/INN)
         D08497  Rupatadine fumarate (JAN)
         D09570  Bilastine (JAN/INN)
         D02249  Emedastine difumarate (JP18/USP)
         D10603  Mite allergen extract
         D10536  Japanese cedar pollen extract
         D08770  Allergen extract (therapeutic)
         D01088  Pemirolast potassium (JP18/USAN)
         D01128  Ramatroban (JAN/INN)
         D01423  Suplatast tosilate (JAN/INN)
         D01654  Bepotastine besylate (USAN); Bepotastine besilate (JP18)
         D01683  Ozagrel hydrochloride hydrate (JAN)
         D02027  Tranilast (JP18/USAN/INN)
         D04990  Monoammonium glycyrrhizinate, glycine and L-cysteine hydrochloride
         D04993  Monoammonium glycyrrhizinate, glycine and DL-methionine
   49  Other agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: April 11, 2024
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version